Search
Descriptor English: Rocuronium
Descriptor Spanish: Rocuronio
Descriptor rocuronio
Entry term(s) (2-beta,3-alfa,5-alfa,16-beta,17-beta)-17-acetato-2-(4-morfolinil)-16-(1-(2-propen-1-il)-1-pirrolidinioil)- androstano-3,17-diol
1-(17-(acetoil)-3-hidroxi-2-(4-morfolinil)androstan-16-il)-1-(2-propenil)pirrolidinio
ORG 9426
ORG-9426
ORG9426
bromuro de 1-((2-beta,3-alfa,5-alfa,16-beta,17-beta)-17-(acetiloxi)-3-hidroxi-2-(4-morfolinil)androstan-16-il)-1-(2-propenil)pirrolidinio
bromuro de rocuronio
esmeron
esmerone
zemuron
Scope note: Bloqueante neuromuscular no despolarizante derivado del androstanol. Tiene una estructura monocuaternaria y es un antagonista nicotínico más débil que el PANCURONIO.
Descriptor Portuguese: Rocurônio
Descriptor French: Rocuronium
Entry term(s): 1-(17-(Acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium
Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-(2-propen-1-yl)-1-pyrrolidiniumyl)-, 17-acetate, (2beta,3alpha,5alpha,16beta,17beta)-
Esmeron
Esmerone
ORG 9426
ORG-9426
ORG9426
Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide
Rocuronium Bromide
Zemuron
Tree number(s): D04.210.500.054.040.783
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000077123
Scope note: An androstanol non-depolarizing neuromuscular blocking agent. It has a mono-quaternary structure and is a weaker nicotinic antagonist than PANCURONIUM.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Neuromuscular Nondepolarizing Agents
Registry Number: WRE554RFEZ
CAS Type 1 Name: Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-(2-propen-1-yl)-1-pyrrolidiniumyl)-, 17-acetate, (2beta,3alpha,5alpha,16beta,17beta)-
Public MeSH Note: 2019; ROCURONIUM was indexed under ANDROSTANOLS 1989-2018
History Note: 2019 (1989)
DeCS ID: 57513
Unique ID: D000077123
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2019/04/29
Rocuronium - Preferred
Concept UI M0171457
Scope note An androstanol non-depolarizing neuromuscular blocking agent. It has a mono-quaternary structure and is a weaker nicotinic antagonist than PANCURONIUM.
Preferred term Rocuronium
Entry term(s) 1-(17-(Acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium
Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-(2-propen-1-yl)-1-pyrrolidiniumyl)-, 17-acetate, (2beta,3alpha,5alpha,16beta,17beta)-
ORG-9426 - Narrower
Concept UI M0171456
Preferred term ORG-9426
Entry term(s) ORG 9426
ORG9426
Esmeron - Narrower
Concept UI M000637147
Preferred term Esmeron
Entry term(s) Esmerone
Zemuron - Narrower
Concept UI M0397869
Preferred term Zemuron
Rocuronium Bromide - Narrower
Concept UI M0171458
Preferred term Rocuronium Bromide
Entry term(s) Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey